Analysis of the discovery dataset (GSE58294, GSE22255) showed a significant decrease in ID3 expression and a significant upregulation of SLC22A4 expression in stroke patient samples compared with controls (Figure 6A, 6B). This evidence concerns the gene SLC22A4 and stroke disorder.